Africa Health Research Institute

What Africa Health Research Institute does

Africa Health Research Institute (AHRI) is an independent, non-profit transdisciplinary scientific research institute headquartered in KwaZulu-Natal, South Africa, with campuses in Durban (co-located with the University of KwaZulu-Natal's Nelson R. Mandela School of Medicine) and Somkhele (a rural site in northern KwaZulu-Natal). The institute pursues optimal health and well-being for under-resourced populations, with research organized around four intersecting content areas—HIV, tuberculosis, emergent/re-emergent infections, and adolescent mental health—and four methodological domains (population, basic and translational, social, and clinical sciences). It operates a Health and Demographic Surveillance System covering 845 km² with >100,000 participants followed longitudinally for approximately 20 years, a Clinical Trials Unit (established 2021) running phase 3-4 trials, an Experimental Science Laboratory with mass spectrometry, flow cytometry, and animal research cores, and a BSL-3 facility exceeding 600 m² alongside an ISO 15189 / SANAS-accredited clinical laboratory.

Its core technology stack is therefore a longitudinal population platform overlaid with accredited wet-lab and clinical trial infrastructure rather than a commercial software product. AHRI does not sell commercial offerings and has no published pricing; revenue is grant-funded through competitive awards, with documented ties to the Bill & Melinda Gates Foundation, Max Planck Society, Ragon Institute (MGH/MIT/Harvard), CAPRISA, NHLS, and over 60 global institutions. The institute is governed by a Board of Directors, led by Executive Director Willem Hanekom (former Gates Foundation TB vaccine group leader), with about 700 scientists, students and staff including 30 faculty members working under a public and community engagement model that treats research participants as active partners in agenda-setting. Its primary “customers” are therefore research participants and South African government health facilities on the demand side, and grant funders and academic collaborators on the supply side of its research output.

Name

Africa Health Research Institute

Legal name

Africa Health Research Institute

Website

https://ahri.org

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

251–500 employees

Short description

Africa Health Research Institute is an independent, non-profit research institute in KwaZulu-Natal, South Africa, conducting transdisciplinary population, clinical, and laboratory research on HIV, TB, emergent infections, and adolescent mental health for under-resourced populations, anchored by a longitudinal HDSS of >100,000 participants and an ISO 15189-accredited BSL-3 facility.

Ownership category

akta.pro rank

Product category

Health Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Social Sciences and Humanities (54172)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Health Information Exchange & Public Health Data Integration (HLAJAJAD)

akta.pro secondary industries

Social Determinants of Health (SDOH) & Equity Measurement (HLAJAJAI), Health Data, Vital Statistics & Population Health Informatics (BPAIAJAM), HIE Platforms & Network Services (Community/Regional/National) (HLACABAB), Health Equity, SDOH & Disparities Measurement (HLAJANAJ), Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships (HLAJAOAL)

Keywords

• Health research services
• Clinical trials research
• Epidemiological surveillance
• Translational medicine research
• Public health research

Headquarters

HQ city

Durban

HQ country

South Africa

HQ region

Africa

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Research Grants and Funding: AHRI operates as a non-profit research institute funded primarily through competitive research grants from prominent funding agencies and international collaborations. The institute collaborates with over 60 global institutions and receives funding from various scientific agencies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Africa Health Research Institute (AHRI) is an independent, transdisciplinary scientific research institute that conducts population, basic and translational, social, and clinical research focused on HIV, TB, emergent infections, and adolescent mental health in under-resourced South African populations. It operates dedicated research infrastructure — a Health and Demographic Surveillance System covering 845 km² with over 100,000 participants, a Clinical Trials Unit, a BSL-3 Experimental Science Laboratory, a Data Science Unit, and a publicly accessible Data Repository — supporting research rather than commercial product delivery.

Product overview

Africa Health Research Institute (AHRI) is an independent scientific research institute that does not offer commercial products but provides research infrastructure and services. The institute operates across four scientific domains—population science, basic and translational science, implementation science, and clinical trials—and four intersecting content areas (HIV, TB, emergent/re-emergent infections, and adolescent mental health). Key offerings include the Health and Demographic Surveillance System (HDSS) covering 845 km² with 100,000+ participants, a Clinical Trials Unit (CTU) supporting phase 3-4 trials, an Experimental Science Laboratory (ESL) with BSL-3 facilities, a Data Science Unit (DSU), and an open Data Repository. These services support research rather than commercial product delivery.

Differentiator

Problem solved

Functional benefit

Products and services

• Health and Demographic Surveillance System (HDSS) A longitudinal population surveillance platform covering 845 km² with over 100,000 participants followed for approximately 20 years, collecting demographic, social, and health data to understand the HIV epidemic impact and monitor intervention strategies. Used by global researchers, policy makers, and partner institutions.
• Clinical Trials Unit (CTU) A research service unit supporting phase three and four clinical trials addressing real world effectiveness questions, with a fully equipped facility at the Somkhele campus including pharmacy, counselling and medical examination rooms, mobile clinics, and sophisticated laboratory infrastructure.
• Experimental Science Laboratory (ESL) Laboratory infrastructure providing specialized core services including pharmacology (mass spectrometry), optics and imaging (microscopy and histology), animal research support, and immunology (flow cytometry-based immune characterisation), backed by over 600m² of BSL-3 laboratory space.
• Data Science Unit (DSU) Provides research data management, biostatistics, and health informatics services including data collection systems, quality checks, data linkage and integration, statistical design and analysis of epidemiological studies, and data archiving.
• AHRI Data Repository A research data platform allowing bona fide researchers to access and download analytical datasets from AHRI studies following necessary approvals by data custodians.

Quantifiable outcome

• HDSS has followed >100,000 participants longitudinally for ~20 years
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and major.

• University of KwaZulu-Natal (UKZN)coreStrategic or Co-development PartnerAHRI-Durban is based at UKZN's Nelson R. Mandela School of Medicine. The partnership provides AHRI with access to academic infrastructure, faculty collaborations, and integration with university research programmes.
• Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE)coreStrategic or Co-development PartnerSANTHE, based at AHRI, is a capacity building programme for biomedical research in Africa. Prof Thumbi Ndung'u has a special interest in capacity building through SANTHE. The programme trains next generation of African scientists.
• South African Government and Policy StakeholderscoreStrategic or Co-development PartnerAHRI works in partnership with local communities and South African academic, governmental, and other policy stakeholders. Research findings inform national health policies and guidelines.
• Over 60 Global Research InstitutionsmajorStrategic or Co-development PartnerAHRI collaborates with over 60 institutions globally including research universities, international health organisations, and scientific networks. These partnerships facilitate joint research projects, data sharing, and scientist exchange programmes.
• Max Planck SocietycoreStrategic or Co-development PartnerProf Thumbi Ndung'u is a Max Planck Society Group Leader, indicating a formal research collaboration between AHRI and the Max Planck Society for advanced research in HIV and TB.
• Ragon Institute of MGH, MIT, and HarvardcoreStrategic or Co-development PartnerProf Bruce Walker, a member of AHRI's Scientific Advisory Committee, is founding director of the Ragon Institute, a major global health research institute focused on immune control and evasion in HIV infection.
• National Health Laboratory Services (NHLS)majorStrategic or Co-development PartnerProf Koleka Mlisana, Chair of AHRI's Scientific Advisory Committee, is CEO of NHLS. This connection facilitates collaboration with South Africa's national laboratory infrastructure.
• Centre for the Aids Programme of Research in South Africa (CAPRISA)coreStrategic or Co-development PartnerProf Salim Abdool Karim, a member of AHRI's Scientific Advisory Committee, is director of CAPRISA. CAPRISA is a leading HIV research centre in South Africa.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Max Planck Institute for Infection Biology: Max Planck Institute for Infection Biology is a global basic/translational infection biology research institute with formal research collaboration with AHRI via Director of Science Thumbi Ndung'u. Comparable in scientific depth and infrastructure but operates at much larger global scale and scope.
• National Institute for Communicable Diseases (NICD) South Africa: NICD is South Africa's national public health institute providing surveillance, reference laboratory services, and outbreak response. Comparable to AHRI in disease surveillance and laboratory capability but broader in mandate (covering all communicable diseases nationally) and government-affiliated.
• Ragon Institute of MGH, MIT, and Harvard: The Ragon Institute is a major global immunology institute focused on immune control and evasion in HIV infection, with AHRI's Scientific Advisory Committee including its founding director Bruce Walker. Comparable in HIV immunology focus but operates at significantly larger scale and global footprint.

Regional players

• MRC/UVRI & LSHTM Uganda Research Unit: Uganda's MRC/UVRI & LSHTM Research Unit is a leading Sub-Saharan African infectious disease research institute conducting HIV, TB, and emerging infection research. Highly comparable in mission and methodology, though it operates in East Africa rather than Southern Africa.
• Africa Population and Health Research Center (APHRC): APHRC is a leading African research institution conducting population health and policy research across East and West Africa. Comparable to AHRI in its population health surveillance approach, SDOH focus, and policy impact, though primarily East African and more focused on social science rather than lab science.
• KEMRI-Wellcome Trust Research Programme: KEMRI-Wellcome Trust Research Programme in Kenya is a leading African clinical and population health research institute combining hospital-based research, HDSS, and clinical trials. Highly comparable to AHRI in integrated surveillance, clinical trials, and basic science approach, though operating in East Africa.

Direct peers

• The Aurum Institute: Aurum Institute is a leading African health research and implementation organization focused on HIV, TB, and COVID-19 clinical trials and public health programs. Comparable to AHRI in its clinical trials capability, large-scale implementation science, and African footprint.
• Desmond Tutu Health Foundation: Desmond Tutu Health Foundation conducts HIV/TB prevention and treatment research in Western Cape townships, with clinical trials, community engagement, and adolescent health programs. It is a direct peer in mission, methodology, and population focus, though operating in a different South African province.
• South African Tuberculosis Vaccine Initiative (SATVI): SATVI is a TB vaccine research group based at the University of Cape Town conducting clinical trials and immunology studies in high-burden settings. It overlaps directly with AHRI's TB vaccine and clinical trials programs and was previously led by AHRI's current Executive Director, Willem Hanekom.
• Centre for the AIDS Programme of Research in South Africa (CAPRISA): CAPRISA is a South African HIV/TB research centre conducting clinical trials, pathogenesis studies, and prevention research in KwaZulu-Natal. It is the closest direct peer to AHRI in geography, disease focus, and clinical trials capability, with overlapping scientific leadership on AHRI's Scientific Advisory Committee.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@ahri
• Xx.com/ahri_news

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Africa Health Research Institute